Tumor Microenvironment-Responsive Nanomedicine: Monitoring and Modulating the Tumor Microenvironment for Precision Cancer Therapy
Open accessThe DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
The tumor microenvironment (TME) is a dynamic and heterogeneous ecosystem whose abnormal vasculature, dense extracellular matrix, metabolic reprogramming and immunosuppression collectively hinder drug penetration, drive therapeutic resistance and limit responses to immunotherapy. TME-responsive nanomedicine provides an emerging toolbox to both monitor and actively remodel the microenvironment for precision cancer therapy. In this narrative review, we first summarize key pathological features of the TME and their impact on drug delivery across classical barriers, including the blood-brain, cutaneous and ocular interfaces, as well as circulating and bone-marrow niches in hematologic malignancies. We then discuss design principles of endogenous and exogenous stimuli-responsive nanoplatforms, and how these systems enable TME monitoring via liquid biopsy, spatial multi-omics and real-time imaging, and TME modulation through metabolic reprogramming, immune activation, vascular normalization and extracellular-matrix remodeling. Finally, we highlight major translational challenges and future opportunities, emphasizing the roles of artificial intelligence, multiscale and quantum-inspired modeling, and closed-loop theranostic strategies in optimizing TME-responsive nanomedicines for clinically meaningful benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in clinical in vivo settings, these hyper-glycolytic tumors create a severely hypoxic, highly acidotic, and immunosuppressive tumor microenvironment (TME), which hinders drug penetration and promotes stemness, ultimately resulting in systemic failure and resistance (15).”
From Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma (2026) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332 · cited 1×
“35 As noted above, dense ECM, elevated tumor interstitial pressure and abnormal vascular perfusion within the TME jointly restrict the effective intratumoral distribution of drugs, so that simply escalating the dose rarely yields a proportional increase in therapeutic efficacy.”
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · cited 1×
“…highly heterogeneously in the clinic: vascular permeability and lymphatic drainage vary markedly between patients, between lesions and even among different regions within the same tumor, resulting in passive accumulation efficiencies far below those predicted from animal models 36 (Figure 2).”
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639 · cited 1×
“163,164 Exosome-based drug delivery platforms 166 and stimulus-responsive polymeric nanoparticles (eg, pH-sensitive liposomes 167 ) have been used in early-phase clinical trials for solid tumor treatment, but have not fully realized the integration of diagnosis, therapy, and feedback.”
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Regulatory T cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2017) · Cell Research · doi:10.1038/cr.2016.151 · Cited by 1,860
Every step of the way: integrins in cancer progression and metastasis
Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031
Chen, P.-L., Roh, W., Reuben, A., Cooper, Z. A., Spencer, C. N., Prieto, P. A., Miller, J. P., Bassett, R. L., Gopalakrishnan, V., Wani, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1545 · Cited by 988
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Tay, C., Tanaka, A., & Sakaguchi, S. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.014 · Cited by 580
LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
Cox, T. R., Bird, D., Baker, A.-M., Barker, H. E., Ho, M. W.-Y., Lang, G., & Erler, J. T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2233 · Cited by 571
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Modulating extracellular matrix stiffness: A strategic approach to boost cancer immunotherapy
Mai, Z., Lin, Y., Lin, P., Zhao, X., & Cui, L. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06697-4 · Cited by 398
Yakoub-Agha, I., Chabannon, C., Bader, P., Basak, G. W., Bonig, H., Ciceri, F., Corbacioglu, S., Duarte, R. F., Einsele, H., Hudecek, M., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.229781 · Cited by 365
Palanikumar, L., Al-Hosani, S., Kalmouni, M., Nguyen, V. P., Ali, L., Pasricha, R., Barrera, F. N., & Magzoub, M. (2020) · Communications Biology · doi:10.1038/s42003-020-0817-4 · Cited by 360
A Manganese Alternative to Gadolinium for MRI Contrast
Gale, E. M., Atanasova, I. P., Blasi, F., Ay, I., & Caravan, P. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10748 · Cited by 353
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Xiang, Y., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 287
Extracellular matrix stiffness: Mechanisms in tumor progression and therapeutic potential in cancer
Zhang, M., & Zhang, B. (2025) · Experimental Hematology & Oncology · doi:10.1186/s40164-025-00647-2 · Cited by 269
pH-Responsive Nanocarriers in Cancer Therapy
AlSawaftah, N. M., Awad, N. S., Pitt, W. G., & Husseini, G. A. (2022) · Polymers · doi:10.3390/polym14050936 · Cited by 268
Lin, L. L., Alvarez-Puebla, R., Liz-Marzán, L. M., Trau, M., Wang, J., Fabris, L., Wang, X., Liu, G., Xu, S., Han, X. X., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c17502 · Cited by 247
AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery
Xu, Y., Ma, S., Cui, H., Chen, J., Xu, S., Gong, F., Golubovic, A., Zhou, M., Wang, K. C., Varley, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50619-z · Cited by 243
Sabit, H., Pawlik, T. M., Radwan, F., Abdel-Hakeem, M., Abdel-Ghany, S., Wadan, A.-H. S., Elzawahri, M., El-Hashash, A., & Arneth, B. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02357-z · Cited by 239
Neuwelt, E. A., Várallyay, P., Bagó, A. G., Muldoon, L. L., Nesbit, G., & Nixon, R. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00557.x · Cited by 219
Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery
Wang, W., Chen, K., Jiang, T., Wu, Y., Wu, Z., Ying, H., Yu, H., Lu, J., Lin, J., & Ouyang, D. (2024) · Nature Communications · doi:10.1038/s41467-024-55072-6 · Cited by 201
Gabizón, A., Gabizon–Peretz, S., Modaresahmadi, S., & La-Beck, N. M. (2025) · BMJ Oncology · doi:10.1136/bmjonc-2024-000573 · Cited by 201
You, Q., Zhang, K., Liu, J., Liu, C., Wang, H., Wang, M., Ye, S., Gao, H., Lv, L., Wang, C., et al. (2020) · Advanced Science · doi:10.1002/advs.201903341 · Cited by 192
Hu, Q., Zhu, Y., Mei, J., Liu, Y. L., & Zhou, G. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01717-y · Cited by 181
Tak, W. Y., Lin, S.-M., Wang, Y., Zheng, J., Vecchione, A., Park, S. Y., Chen, M. H., Wong, S., Xu, R., Peng, C.-Y., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2433 · Cited by 167
Zou, J., Jiang, C., Hu, Q., Jia, X., Wang, S., Wan, S., Mao, Y., Zhang, D., Zhang, P., Dai, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55658-0 · Cited by 142
Self-citationTransferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
Ramalho, M. J., Loureiro, J. A., Coelho, M. A. N., & Pereira, M. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020279 · Cited by 134
Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside
Abdullah, K. M., Sharma, G., Singh, A. P., & Siddiqui, J. A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02368-w · Cited by 134
BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth
Wang, T., Xiao, M., Ge, Y., Krepler, C., Belser, E., Lopez-Coral, A., Xu, X., Zhang, G., Azuma, R., Liu, Q., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1554 · Cited by 132
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Chen, Y., Liu, X., Yuan, H., Yang, Z., von Roemeling, C. A., Qie, Y., Zhao, H., Wang, Y., Jiang, W., & Kim, B. Y. S. (2019) · Advanced Science · doi:10.1002/advs.201802070 · Cited by 130
Lyu, N., Hassanzadeh‐Barforoushi, A., Gomez, L. M. R., Zhang, W., & Wang, Y. (2024) · Nano Convergence · doi:10.1186/s40580-024-00428-3 · Cited by 127
Fu, S., Zhu, X., Fanghua, H., & Chen, X. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17081074 · Cited by 125
Xu, M., & Li, S. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216397 · Cited by 119
Ding, Y., Sun, Z., Tong, Z., Zhang, S., Min, J., Xu, Q., Zhou, L., Mao, Z., Xia, H., & Wang, W. (2020) · Theranostics · doi:10.7150/thno.45017 · Cited by 113
Xiao, W., Song, M., Li, W., Huang, J., Yang, G. Y., & Wang, Y. (2021) · Theranostics · doi:10.7150/thno.59342 · Cited by 111
Li, H., Wang, M., Huang, B., Zhu, S.-W., Zhou, J.-J., Chen, D.-R., Cui, R., Zhang, M., & Sun, Z.-J. (2021) · Nature Communications · doi:10.1038/s41467-021-27485-0 · Cited by 110
Wu, Y., Shao, W., Yan, M., Wang, Y., Xu, P., Huang, G., Li, X., Gregory, B. D., Yang, J. M., Wang, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48437-4 · Cited by 110
In vivo surface-enhanced Raman scattering techniques: nanoprobes, instrumentation, and applications
Chang, H., Hur, W., Kang, H., & Jun, B. (2025) · Light Science & Applications · doi:10.1038/s41377-024-01718-5 · Cited by 108
A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research
Mendes, B. B., Zhang, Z., Conniot, J., Sousa, D. P., Ravasco, J. M. J. M., Onweller, L. A., Lorenc, A., Rodrigues, T., Reker, D., & Conde, J. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01673-7 · Cited by 108
Wu, M., Chen, W., Chen, Y., Zhang, H., Liu, C., Deng, Z., Sheng, Z., Chen, J., Liu, X., Yan, F., et al. (2018) · Advanced Science · doi:10.1002/advs.201700474 · Cited by 104
Wang, Y., Li, H., Lin, J., Li, Y., Zhang, K., Li, H., Fu, Q., & Jiang, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-57190-1 · Cited by 103
Self-citationMachine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery
Wang, Q., Liu, Y., Li, C., Xu, S., Xu, S., & Liu, B. (2025) · Advanced Science · doi:10.1002/advs.202503138 · Cited by 102
Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles
Bodnár, K., Fehér, P. S., Ujhelyi, Z., Bácskay, I., & Józsa, L. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040449 · Cited by 98
Borys, N., & Dewhirst, M. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113985 · Cited by 97
Stimuli‐Responsive Nanotechnology for RNA Delivery
Zhou, H., Chen, D. S., Hu, C. J., Hong, X., Shi, J., & Xiao, Y. (2023) · Advanced Science · doi:10.1002/advs.202303597 · Cited by 94
Wang, W., Liu, X., Zheng, X., Jin, H. J., & Li, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001117 · Cited by 93
Sela, M., Poley, M., Mora‐Raimundo, P., Kagan, S., Avital, A., Kaduri, M., Chen, G., Adir, O., Rozencweig, A., Weiss, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202304654 · Cited by 91
Tumor Microenvironment-Adaptive Nanoplatform Synergistically Enhances Cascaded Chemodynamic Therapy
Wang, Y., Wang, D., Zhang, Y., Xu, H., Shen, L., Cheng, J., Xu, X., Tan, H. S., Chen, X., & Li, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.09.025 · Cited by 88
Modulation of T2 Relaxation Time by Light-Induced, Reversible Aggregation of Magnetic Nanoparticles
Osborne, E. A., Jarrett, B. R., Tu, C., & Louie, A. Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100254m · Cited by 84
Shao, M., Lopes, D., Lopes, J., Yousefiasl, S., Macário‐Soares, A., Peixoto, D., Ferreira-Faria, I., Veiga, F., Conde, J., Huang, Y., et al. (2023) · Matter · doi:10.1016/j.matt.2023.01.012 · Cited by 82
Yuan, S., Hu, D., Gao, D., Butch, C. J., Wang, Y., Zheng, H., & Sheng, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03572-y · Cited by 80
Stimuli‐activatable nanomedicines for chemodynamic therapy of cancer
Wang, W., Jin, Y., Xu, Z., Liu, X., Bajwa, S. Z., Khan, W. S., & Yu, H. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1614 · Cited by 79
Wei, R., Gong, X., Lin, H., Zhang, K., Li, A., Liu, K., Shan, H., Chen, X., & Gao, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01900 · Cited by 79
Tang, X., Feng, J., Ben-lan, L., Cui, S., Yu, R., Shen, X., & Wang, T. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b19797 · Cited by 78
Polysaccharide-based nanocarriers for efficient transvascular drug delivery
Zhang, M., Ma, H., Wang, X., Yu, B., Cong, H., & Shen, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.051 · Cited by 77
Blood-brain Barrier Crossing using Magnetic Stimulated Nanoparticles
Chen, J., Yuan, M., Madison, C. A., Eitan, S., & Wang, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.007 · Cited by 76
Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions
Huhulea, E. N., Huang, L., Eng, S., Sumawi, B., Huang, A., Aifuwa, E., Hirani, R., Tiwari, R. K., & Etienne, M. (2025) · Biomedicines · doi:10.3390/biomedicines13040951 · Cited by 74 · cited 1×
“180,181 A more forward-looking direction is upgrading AI from a design tool to an in-course closed-loop controller.”
Biomimetic Nanoparticles for Basic Drug Delivery
Tikhonov, A., Kachanov, A., Yudaeva, A., Danilik, O., Ponomareva, N. I., Karandashov, I. V., Kostyusheva, A. P., Zamyatnin, A. A., Parodi, A., Chulanov, V., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101306 · Cited by 73
Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases
Su, Y., Chen, M., Xu, W., Gu, P., & Fan, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c08486 · Cited by 73
Mitochondrial Amount Determines Doxorubicin‐Induced Cardiotoxicity in Cardiomyocytes
Xiong, W., Li, B., Pan, J., Li, D., Yuan, H., Wan, X., Zhang, Y., Fu, L., Zhang, J., Lei, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202412017 · Cited by 70
Abate, M. F., Jia, S., Ahmed, M. G., Li, X., Lin, L., Chen, X., Zhu, Z., & Yang, C. J. (2019) · Small · doi:10.1002/smll.201804890 · Cited by 69
Dong, Z., Liu, Y., Wang, C., Hao, Y., Fan, Q., Yang, Z., Li, Q., Feng, L., & Liu, Z. (2023) · Advanced Materials · doi:10.1002/adma.202308254 · Cited by 68
Deng, X., Liu, X., & Zhao, L. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102385 · Cited by 66
Mojarad-Jabali, S., Farshbaf, M., Hemmati, S., Sarfraz, M., Motasadizadeh, H., Mojarrad, J. S., Atyabi, F., Zakeri‐Milani, P., & Valizadeh, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121395 · Cited by 64
Sun, Q., Li, Y., Shen, W. H., Shang, W., Xu, Y., Yang, J., Chen, J., Gao, W., Wu, Q., Xu, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202310673 · Cited by 60
Self-citationFang, T., Cao, X., Wang, L., Chen, M., Deng, Y., & Chen, G. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.023 · Cited by 57
Chen, M., Shen, Y., Pu, Y., Zhou, B., Bing, J., Ge, M., Zhu, Y., Gao, S., Wu, W., Zhou, M., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122386 · Cited by 55
Cheng, Y. S., Lu, T., Wang, Y., Song, Y., Wang, S., Lu, Q., Yang, L., Tan, F., Li, J., & Li, N. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00332 · Cited by 55
Li, J., Wang, Q., Han, Y., Jiang, L., Lu, S., Wang, B., Qian, W., Zhu, M., Huang, H., & Qian, P. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01460-2 · Cited by 55
Manganese-derived biomaterials for tumor diagnosis and therapy
Huang, P., Tang, Q., Li, M., Yang, Q., Zhang, Y., Lei, L., & Li, S. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02629-8 · Cited by 55
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles
Sundaram, V., & Aryal, S. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70025 · Cited by 54
Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases
Lin, X., Zhou, Y., Lv, K., Wu, W., & Chen, C. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s532074 · Cited by 53
Machine learning reshapes the paradigm of nanomedicine research
Wei, Z., Zhuo, S., Zhang, Y., Wu, L., Gao, X., He, S., Bo, X., & Zhou, W. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.014 · Cited by 53
Dai, Z., Wang, Q., Tang, J., Qu, R., Wu, M., Li, H., Yang, Y., Xu, Z. C., & Yu, C. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121533 · Cited by 53
Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy
Huang, Q., Tong, F., Chen, J., Kayumov, M., Lv, Y., Shi, Y., Ye, B., & Gao, H. (2025) · Advanced Science · doi:10.1002/advs.202513567 · Cited by 50
Breaking barriers with pH-responsive nanocarriers: a new frontier in precision oncology
Tapponi, S. L., Yusuf, A., Alsaafin, F., & Hussain, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125931 · Cited by 48
Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy.
Guo, H., Guo, M., Xia, Z., & Shao, Z. (2024) · PubMed Central · doi:10.12336/biomatertransl.2024.01.004 · Cited by 47
Zhang, P., Zhong, D., Yu, Y., Wang, L., Li, Y., Liang, Y., Shi, Y., Duan, M., Li, B., Niu, H., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122695 · Cited by 46
Self-citationResponsive DNA artificial cells for contact and behavior regulation of mammalian cells
Wang, M., Nan, H., Wang, M., Yang, S. Z., Liu, L., Wang, H., & Nie, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-57770-1 · Cited by 46
Thermosensitive liposomes: a promising step toward localised chemotherapy
Chaudhry, M., Lyon, P. C., Coussios, C. C., & Carlisle, R. C. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2099834 · Cited by 46
Waitkus, M. S., Pirozzi, C. J., Moure, C. J., Diplas, B. H., Hansen, L. J., Carpenter, A. B., Yang, R., Wang, Z., Ingram, B. O., Karoly, E. D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1352 · Cited by 45
Lencioni, R., & Cioni, D. (2016) · Hepatic Oncology · doi:10.2217/hep-2016-0005 · Cited by 44
Xia, W., Li, C., Chen, Q., Huang, J., Zhao, Z., Liu, P., Xu, K., Li, L., Hu, F., Zhang, S., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.022 · Cited by 44
Liu, Z., Ba, Y., Shan, D., Zhou, X., Zuo, A., Zhang, Y., Xu, H., Liu, S., Liu, B., Zhao, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115555 · Cited by 43
Wang, D., Ma, W., Zhang, Y., Wang, Y., Sun, L., Jiang, J., Jiao, L., Li, R., Zhang, Y., Zhang, Y., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122778 · Cited by 43
Xu, P., Wang, R., Yang, W., Liu, Y., He, D., Ye, Z., Chen, D., Ding, Y., Tu, J., & Shen, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00824-5 · Cited by 43
Metabolism‐Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy
Liu, C., Xu, X., Chen, Y., Yin, M., Mäkilä, E. M., Zhou, W., Su, W., & Zhang, H. (2024) · Small · doi:10.1002/smll.202307794 · Cited by 42
Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment
Abousalman‐Rezvani, Z., Refaat, A., Dehghankelishadi, P., Roghani‐Mamaqani, H., Esser, L., & Voelcker, N. H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302902 · Cited by 42
Duffield, C., Gomez, L. M. R., Tsao, S. C., & Wang, Y. (2024) · Nanoscale · doi:10.1039/d4nr04014g · Cited by 40
Singh, S., Ghosh, C., Roy, P., & Pal, K. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121831 · Cited by 40
Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy
Xiong, W. H., Guo, Z., Zeng, B., Wang, T., Zeng, X., Cao, W., & Lian, D. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.847901 · Cited by 40
Ma, L., & Cheng, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.079 · Cited by 39
The role of manganese-based MRI contrast agents for cancer theranostics: Where do we stand in 2025?
Zhang, L., Roy, S., & Guo, B. (2025) · Theranostics · doi:10.7150/thno.108705 · Cited by 39
Yuan, G., Liu, Z., Wang, W., Liu, M., Xu, Y., Hu, W. M., Fan, Y., Zhang, X., Liu, Y., & Si, G. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01820-7 · Cited by 39
Abdi, B., Mofidfar, M., Hassanpour, F., Cilingir, E. K., Kalajahi, S. K., Milani, P. H., Ghanbarzadeh, M., Fadel, D., Barnett, M., Ta, C. N., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122740 · Cited by 38
Tumor Microenvironment-Responsive Nanoparticles: Promising Cancer PTT Carriers
Sun, H., Li, Y., Xue, M., & Feng, D. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s526497 · Cited by 37
Self-citationHou, J., Xue, Z., Chen, Y., Li, J., Yue, X., Zhang, Y., Gao, J., Hao, Y., & Shen, J. Q. (2025) · Polymers · doi:10.3390/polym17081010 · Cited by 36
Feng, Q., Fatima, K., Ai, Y., Li, C., Chen, S., Yang, G., Zhou, X., & He, C. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.03.022 · Cited by 36
Ailioaie, L. M., Ailioaie, C., & Litscher, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072969 · Cited by 36
Piotrowska, U., Tsoi, J. K. H., Singh, P., Banerjee, A., & Sobczak, M. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01062 · Cited by 34
bigdeli, A., Makhmalzadeh, B. S., Feghhi, M., & SoleimaniBiatiani, E. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01266-8 · Cited by 34
Cui, G., Deng, S., Zhang, B., Wang, M., Lin, Z., Lan, X., Li, Z., Yao, G., Yu, M., & Yan, J. (2024) · Advanced Science · doi:10.1002/advs.202402107 · Cited by 33
Klapproth, A. P., Schuemann, J., Stangl, S., Xie, T., Li, W. B., & Multhoff, G. (2021) · Cancer Nanotechnology · doi:10.1186/s12645-021-00099-3 · Cited by 33
Monte Carlo Simulations in Nanomedicine: Advancing Cancer Imaging and Therapy
Chow, J. C. L. (2025) · Nanomaterials · doi:10.3390/nano15020117 · Cited by 32
Water‐Stable Magnetic Lipiodol Micro‐Droplets as a Miniaturized Robotic Tool for Drug Delivery
Ren, E., Hu, J., Mei, Z., Lin, L., Zhang, Q., He, P., Wang, J., Sheng, T., Chen, H., Cheng, H., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412187 · Cited by 32
Li, G., Jin, Q., Xia, F., Fu, S., Zhang, X., Xiao, H., Tian, C., Lv, Q., Sun, J., He, Z., et al. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0003 · Cited by 32
Dong, Y.-F., Li, Y.-S., Liu, H., Li, L., Zheng, J., Yang, Z.-F., Sun, Y., Du, Z., Xu, D., Li, N., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.017 · Cited by 30
Self-citationFontana, F., Scott, M. J., Allen, J. S., Yang, X., Cui, G., Pan, D., Yanaba, N., Fiala, M. A., O’Neal, J., Schmieder-Atteberry, A. H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2839 · Cited by 29
Hierarchical Crack Engineering-Enabled High-Linearity and Ultrasensitive Strain Sensors
Xu, Z., Xiao, W., Deng, K., Zhang, Y., Shen, T., Liu, X., Ding, Z., Tan, Q., & Wu, D. (2025) · ACS Sensors · doi:10.1021/acssensors.4c03572 · Cited by 29
Iqbal, H., Razzaq, A., Liu, F., Zhang, F., Tao, J., Li, T., Jiang, Y., Zhao, Z., Qin, M., Lin, X., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.001 · Cited by 29
Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy
Liang, R., Cheng, A., Lu, S., Zhang, X.-K., Ren, M., Lin, J., Wu, Y., Zhang, W., & Luan, X. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95484 · Cited by 29
Wang, R., Hastings, W. J., Saliba, J. G., Bao, D., Huang, Y., Maity, S., Ahmad, O. M. K., Hu, L., Wang, S., Fan, J., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c11505 · Cited by 28
Tran, H. H., Xiang, Z., Oh, M. J., Liu, Y., Ren, Z. F., Chen, C., Jaruchotiratanasakul, N., Kikkawa, J. M., Lee, D., Koo, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c11686 · Cited by 28
Yabhouni, S. A. A., Mozumder, M. S., Hassan, N., Mourad, A. I., & Issa, T. M. A. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124899 · Cited by 28
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs
Meagher, R. B., Lewis, Z., Ambati, S., & Lin, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114776 · Cited by 27
Xie, Q., Sun, T., Zhang, L., Gong, M., Zhang, W., Liu, X., Zhao, Y., Wang, M., Yang, X., Zhang, Z., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122971 · Cited by 27
Pallarès, V., Unzueta, U., Falgàs, A., Aviñó, A. M., Núñez, Y., García‐León, A., Sánchez‐García, L., Serna, N., Gallardo, A., Alba‐Castellón, L., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121258 · Cited by 27
All-stage targeted therapy for the brain metastasis from triple-negative breast cancer
Luo, Z., Wu, S., Zhou, J., Xu, W., Xu, Q., Lu, L., Xie, C., Liu, Y., & Lu, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.026 · Cited by 27
Liu, Y., Li, H., Hao, Y., Huang, L., Li, X., Zou, J., Zhang, S., Yang, X., Chen, H., Guo, Y., et al. (2024) · Small · doi:10.1002/smll.202406870 · Cited by 27
Bhatt, J., Jain, S., Gupta, S. K., & Bhatia, D. D. (2025) · Nanoscale Advances · doi:10.1039/d5na00390c · Cited by 27
Zhu, L., Mao, H. Z., & Yang, L. P. H. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1793 · Cited by 26
Javid, H., Oryani, M. A., Rezagholinejad, N., Hashemzadeh, A., & Karimi‐Shahri, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00281d · Cited by 25
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Wu, X., Wang, F., Yang, X., Gong, Y., Niu, T., Chu, B., Qu, Y., & Qian, Z. (2024) · Small · doi:10.1002/smll.202403409 · Cited by 25
Ding, L., Zhang, X., Wang, P., Ke, J., Zhou, Y., Wu, M., Wei, Z., Cao, Y., Li, H., Chen, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63311-7 · Cited by 25
Chen, M., Qiu, P., He, X., Wang, K., Chen, S., Yang, S., & Ye, X. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00103f · Cited by 25
Liu, W.-L., Zhang, Y., Luo, X., Zhu, Y., Song, L., Ming, Z., Zhang, L.-X., Li, M.-J., Lv, R., Zhang, G., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417944 · Cited by 24
Stimuli-Responsive Nanomaterials for Tumor Immunotherapy
Li, X., Hou, D., Wu, J.-C., Zhang, P., Wang, Y.-Z., Lv, M.-Y., Yi, Y., & Xu, W. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00388 · Cited by 23
Theivendran, S., Xian, H., Qu, J., Song, Y., Sun, B., Song, H., & Yu, C. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c04706 · Cited by 23
Jia, B., Gao, Y., Ouyang, Z., Shen, S., Shen, M., & Shi, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00568b · Cited by 23
Chen, Q., Xu, Y., Yu, Y., Duan, X., Ni, R., Song, G., Zhu, L., Zhong, Y., Qu, K., Qin, X., et al. (2025) · Small · doi:10.1002/smll.202408980 · Cited by 22
Dynamic carboxymethyl chitosan-based nano-prodrugs precisely mediate robust synergistic chemotherapy
Wang, Z., Wang, D., Liu, X., Wu, H., Liu, Y., Ge, Y., Yan, G., & Tang, R. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119671 · Cited by 22
Recent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration
Zhu, L. Q., Jiang, Y., Tian, H., Yu, Y., Gan, Y., Li, H., Yuan, M., Huang, X., & Liu, X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s529003 · Cited by 21
Theranostic nanoparticles for detection and treatment of pancreatic cancer
Agarwal, H., Bynum, R. C., Saleh, N., Harris, D., MacCuaig, W. M., Kim, V., Sanderson, E. J., Dennahy, I. S., Singh, R., Behkam, B., et al. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1983 · Cited by 21
Pan, Z., Lu, X., Hu, X., Yu, R., Che, Y., Wang, J., Lin, X., Chen, J., Yi, X., Tan, Z., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.057 · Cited by 21
Wang, L., Xia, J., Fan, H., Hou, M., Wang, H., Wang, X., Zhang, K., Cao, L., Liu, X., Ling, J., et al. (2021) · Theranostics · doi:10.7150/thno.61651 · Cited by 21
Jiang, S., Hao, B., Song, X., Jiang, Y., Guo, J., Wang, Y., Wang, Q., Wang, X., Xu, T., Wu, X., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403866 · Cited by 20
Why tumour geography matters — and how to map it
Eisenstein, M. S. (2024) · Nature · doi:10.1038/d41586-024-03830-3 · Cited by 20
Advancements in Nanomaterials and Molecular Probes for Spatial Omics
Lin, Y., Hou, J., Li, B., Shu, W., & Wan, J. (2025) · ACS Nano · doi:10.1021/acsnano.4c18470 · Cited by 19
Zhao, Y., Zhang, X., Bai, J., Jia, H.-Y., Chen, M., & Wang, J. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04366 · Cited by 19
Minini, M., Avveduto, G., Becharef, S., Meunier--Thaens, M., Lekbaby, B., Pérez-Lanzón, M., Machado, A., Guilbert, T., Lesieur, J., Renault, G., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001545 · Cited by 19
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
Dang, M., & Shoichet, M. S. (2023) · Advanced Science · doi:10.1002/advs.202306463 · Cited by 18
Wang, P., Sun, Y., Jin, W., Cheng, J., Peng, H.-X., Xu, Y., Zhou, K., Chen, L., Huang, K., Wu, S., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12876 · Cited by 18
Nguyen, T. M., Nguyen, T. M. T., Kim, S., Kang, S. K., Lee, S., Jung, Y. J., Kim, H. Y., & Oh, J. (2025) · ACS Sensors · doi:10.1021/acssensors.4c03051 · Cited by 18
Synthetic syntrophy for adenine nucleotide cross-feeding between metabolically active nanoreactors
Heinen, L., van den Noort, M., King, M. S., Kunji, E. R. S., & Poolman, B. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01811-1 · Cited by 18
Li, Y., Jin, L., Tao, B., Li, X., Shi, H., Qin, Y., Hao, Y., Li, Q., Feng, Q., Li, T., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07277-6 · Cited by 17
Self-citationZeeshan, M., Ain, Q., Sunny, A., Raza, F., Mohsin, M. J., Khan, S., Weigmann, B., & Ali, H. (2022) · Biomaterials Science · doi:10.1039/d2bm01719a · Cited by 17
Jia, Q., Li, Z., Bai, M., Yan, H., Zhang, R., Ji, Y., Feng, Y., Yang, Z., Wang, Z., & Li, J. (2021) · Theranostics · doi:10.7150/thno.65771 · Cited by 17
Advances in nanomaterials for enhancing cGAS-STING pathway mediated anti-tumor treatment
Wu, R., Wang, J., Li, D., Li, A., Yoo, K. H., Liu, Z., Wei, W., Wang, Z., & Feng, D. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102190 · Cited by 16
Hou, J., Liu, H., Ma, Q., Xu, S., & Wang, L. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01341 · Cited by 16
Advances in Transdermal Delivery Systems for Treating Androgenetic Alopecia
Xu, S., Zhou, L., Zhao, H., & Li, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17080984 · Cited by 16
Yan, J., Qi, Y., Liu, Y., Jiang, X., Li, Y., Song, Z., Zhang, L., & Zhang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115390 · Cited by 15
Self-citationNizioł, J., Krupa, S., Szuberla, W., & Ruman, T. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344256 · Cited by 15
Li, M., Liu, Z., Peng, D., Liu, Y., Cheng, L., Chen, B., & Liu, J. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.02.045 · Cited by 14
Zhang, Y., Ge, X., Gao, S., & Song, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.026 · Cited by 14
Filippo, L. D. D., de Paula, M. C., Duarte, J. L., de Paula, G. A., Frigieri, I., & Chorilli, M. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2221026 · Cited by 14
Zong, S., Tang, H., Yang, K., Wang, H., Wang, Z., & Cui, Y. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01211d · Cited by 14
Nanomaterials Application for STING Pathway-Based Tumor Immunotherapy
Zhao, W., Tang, X., Qin, Y., Wang, X., Zhong, K., Gong, N., & Li, T. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s535460 · Cited by 12
Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole
Sikhondze, S., Makoni, P. A., Walker, R. B., & Khamanga, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071855 · Cited by 12
The curious case of anti-PEG antibodies
Denman, D. S., & Dalhaimer, P. (2025) · Nanoscale · doi:10.1039/d5nr02301g · Cited by 11
Wu, H., Sun, X., Li, K., Li, J., Jiang, H., Yan, D., Ya, L., Ding, Y., Lu, Y., Zhu, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202409790 · Cited by 11
GSH-responsive magnetic imaging for in situ monitoring of tumor chemodynamic therapy
Lu, J. G., Jiang, Z., Chen, X., Zhang, W., Li, P., Tang, Y., Zhang, W., Wang, H., & Tang, B. (2025) · Chemical Science · doi:10.1039/d5sc04436g · Cited by 11
Nanotechnology in Hematology: Enhancing Therapeutic Efficacy With Nanoparticles
Fard, N. T., Khademi, M., Salahi‐Niri, A., & Esmaeili, S. (2025) · Health Science Reports · doi:10.1002/hsr2.70647 · Cited by 10
Chen, Y., Fan, Z., Xu, W., Zhu, Z., Tan, Z., Hu, Y., Kurzina, I. A., Чердынцева, Н. В., Yang, W. J., & Wang, L. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.01.146 · Cited by 10
Two-plex in vivo molecular imaging in the second near-infrared window for immunotherapeutic response
Sun, Y., Li, R., Cai, Y., Liu, Y., Wang, P., Wu, M., Zhang, X., Liao, N., Zhang, C., Zheng, A., et al. (2025) · Theranostics · doi:10.7150/thno.108880 · Cited by 10
Emerging lipid nanoparticle systems capable of efficient intramuscular RNA delivery
Raza, A., Zhang, R., Lu, R., Wen, J., & Wu, W. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2555507 · Cited by 9
Nano-inspired smart medicines targeting brain cancer: diagnosis and treatment
Anand, R., Kumar, L., Mohan, L., & Bharadvaja, N. (2022) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-022-01981-0 · Cited by 6
Rivandi, M., Franken, A., Yang, L., Abramova, A., Stamm, N., Eberhardt, J., Gierke, B., Beer, M., Fehm, T. N., Niederacher, D., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05616-7 · Cited by 5
Research works printed but not linked: 2
- Netti, 2000, Cancer Res, 60, 2497
- Gabizon, 1994, Cancer Res, 54, 987
Cited by
Parvin, N., Park, K., Jung, J. H., & Mandal, T. K. (2026) · Antibiotics · doi:10.3390/antibiotics15070638 · Cited by 4
Recent advances in hybrid membrane vesicles as a programmable biomimetic drug delivery
Chen, Y., Yuan, X., Huang, Y., Wei, Q., & Zhang, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115244 · Cited by 3
Rahaman, Jalouli, M., Harrath, A. H., Choi, J., Choi, M., Kim, H. S., Park, S., Shim, B., Rani, A., & Kim, B. (2026) · Cells · doi:10.3390/cells15100850 · Cited by 2
Moharana, A. K., Barik, B., & Santhosh, A. J. (2026) · Cancer Nanotechnology · doi:10.1186/s12645-026-00385-y · Cited by 1
Zhang, C., Shu, B., Wang, X., Shen, X., Du, Y., Yang, J., & Miao, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1845672 · Cited by 1
Metadata
- Authors
- He, J., Xue, W., & Li, Y.
- Affiliations
- Qinghai University (CN)
- Corresponding author
- Li, Yan
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2026-03
- Volume
- Volume 21
- Pages
- 1-38
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC13011976
- OpenAlex
- W7138845632
- Cited by
- 16
- References
- 189
- Citations by year
- 2026: 16
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, stimuli-responsive nanomedicine, precision cancer therapy, drug delivery barriers, blood-brain barrier, ocular drug delivery, bone marrow microenvironment, hematologic malignancies, liquid biopsy, spatial multi-omics, real-time imaging, metabolic reprogramming, immune activation, vascular normalization, extracellular matrix remodeling, immunosuppression, treatment resistance, artificial intelligence in drug design, quantum-inspired modeling
- MeSH terms
- Theranostic Nanomedicine, Animals, Antineoplastic Agents, Humans, Neoplasms, Drug Delivery Systems, Nanomedicine, Nanoparticles, Precision Medicine, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.